Team
Doug McCormack

Doug McCormack

Advisor

LinkedIn

Doug has spent nearly 30 years working at the intersection of health care, law, and entrepreneurism. He has been the founder and CEO of venture-backed technology companies in the medical device, digital health, and robotics sectors. In 2013, Fierce Medical Devices named him one of the Fierce 15 emerging CEOs in medical devices. Before his entrepreneurial career, Doug was a partner in a global law firm’s Washington office, where he focused on medical technology and policy. Doug is a graduate of the University of Southern California and the American University’s Washington College of Law. He is currently the founder and CEO of Gauntlet Technologies, a commercialization and strategic development firm focused on deep technology.

Insights

The content and distribution of Azafran’s INSIGHTS newsletter is focused to our LP, incubator, research, investment and partner ecosystem. As we look to build a two-way dialogue benefitting our collective efforts, each month we highlight important news and our approach to the emerging intersection of deep technology, end to end solutions and platforms driven by voice, acoustics/sensory and imagery.

The content and distribution of Azafran’s INSIGHTS newsletter is focused to our LP, incubator, research, investment and partner ecosystem. Below are highlights from the last two issues, please sign up to receive access to past and new issues as they are published.

Subscribe to our newsletter

  • Issue 18 - The Impact of Deep Tech + Imagery on the Future of Healthcare

    In the second issue of our Special Report Series, we turn our focus to the imagery modality and the impacts already being felt in the future of healthcare.

    Read more
  • Issue 18 - tagSpace: Augmented Reality for the Masses, now Covid Ready

    tagSpace (Azafran Portfolio I) provides a no-code solution for location-based Augmented Reality - With a focus on markets such as music festivals, events and experiences, tagSpace has pivoted to also helping fight the spread of Covid-19.

    Read more

© Copyright 2017 - 2020, Azafran Capital Partners, Inc.